Dr. Juan J. Carmona, g’10, ph’10, ph’14, m’16, is an accomplished biomedical scientist and medical affairs professional with over a decade of experience leading senior cross-functional teams at top-tier institutions across industry, academia, clinical institutes, and hospitals. He has made significant contributions to various disease and therapeutic areas, including oncology and infectious disease.
Dr. Carmona completed his scientific education and training at Harvard University, earning a PhD in cell and developmental biology, a Master of Public Health in family and community health, and a Master of Bioethics with a focus on the ethics of genomic data in industry and healthcare. He was awarded the prestigious Alonzo Smythe Yerby Postdoctoral Fellowship at the Chan School, where he later became an independent NIH-funded Visiting Scientist.
Throughout his career, Dr. Carmona has excelled in various roles. At the Brigham and Women’s Multi-Regional Clinical Trials Center, he specialized in data ethics and tailored clinical study designs in collaboration with pharmaceutical and biotechnology leaders. At Dana-Farber Cancer Institute, he managed clinical study compliance and the licensing of intellectual property in partnership with startups related to the institute. At Philips Research North America, he contributed to award-winning work in new product development, research and business development, competitive intelligence, and operational risk management.
Currently, Dr. Carmona serves as the founding Director of Scientific Affairs and Professional Alliances at OraSure Technologies, Inc., a world leader in point-of-care and at-home diagnostic testing, as well as non-invasive self-sampling technologies and microbiome-related solutions. In this role, he oversees scientific and clinical affairs, key opinion leader (KOL) engagement, scientific evidence generation and dissemination, and clinical research roadmap and compliance management.
In addition to his professional achievements, Dr. Carmona has been an active member of the Harvard Club of Boston since 2003. He has served on several committees and task forces, including the House Committee (2020-Pres.), Fine Arts Committee (2020-Pres.), Committee to Affirm Respect and Equity Standards (CARES) (2020-Pres.), Facility Planning Committee (2019-Pres.), Member Engagement Committee (2018-2020), and the Membership & Marketing Committee (2016-2017). He has served as a Board member since 2021 and was appointed House Chair in 2022.